Pregnenolone CRT -
Pregnenolone CRT™ features a Controlled Release Technology that provides a very slow (10-12 hour) continuous release of pregnenolone, helping to eliminate the spikes or surges that may be associated with other delivery systems.* Ultimately, this CRT™ technology more closely mimics the way pregnenolone is normally released within the body.
This translates to a controlled delivery system that allows for convenient once-daily dosing, a feature very important in hormone precursor therapy. Pregnenelone is a hormone manufactured from cholesterol in the mitochondria whose optimal levels may have a positive effect on:
Ultimately, this technology delivers optimal results by enabling pregnenolone to be released in such a way that it more closely mimics how it is released within the body.